The Symple app for iPhone allows patients to track their daily symptoms and the factors that influence those symptoms–like a new medication, yoga, or going gluten-free–between doctor visits. They can also create a visual diary of their condition and build a list of questions to ask their doctors. We think it seems like a great tool to help patients take control of their health. A similar app could be handy for researchers in collecting data and reports from clinical trial participants, and could make participation easier and more convenient for volunteers.
Lilly COI’s main focus is on driving innovation in clinical drug development. However, we do understand that clinical drug development is only a small part of the overall Healthcare Ecosystem. We strongly support open innovative methods to drive value to patients throughout the entire ecosystem.
We also are committed to working locally with the gifted and inventive talent in our community to help create a patient-centric culture in healthcare.
For these reasons, we are thrilled to have the honor of sponsoring and hosting Indiana’s first ever health-focused codeathon, Hoosier Code for Health, in partnership with Social Health Insights, Lodestone Logic and the Indy Chamber.
The codeathon will take place on Saturday, July 13 from 8 a.m. to 8 p.m. and on Sunday, July 14 from 8 a.m. to 1 p.m at the Lilly COI Center.
What is a codeathon?
Over the past month I’ve attended and presented at a couple of conferences. The first was Partnerships in Clinical Trials, a gather of 1000+ professionals involved in clinical research. The second was the Evolution Summit. (I’ve included my presentations at both below).
It was great to see a number of leaders I’ve come to know and respect including Craig Lipset of Pfizer, Tomasz Sablinski of TLC, and Deirdre BeVard of Endo. To me, conferences are more about making and growing relationships than they are about specific content. That said, the highlight of the Partnerships conference for me was a presentation by Eric Topol on disruptive changes in medicine and how this will impact drug development. More…
Advances in computational science and biology enable us to understand ourselves in ways that we could not just a few years ago. Co-founded in 2006 by Anne Wojcicki, wife of Google co-founder Sergey Brin, 23andMe has emerged in the digital age to provide a view of our personal genetics - all for less than $100!
23andMe is evidence of Moore’s Law at work, and, in addition to giving unprecedented insight into our personal genome, efforts like 23andMe have innovative potential to change the way drugs are found and developed.
Thanks to Moore’s law, the cost per Human Genome is falling rapidly. More…